Mobimo Holding AG (0QQY)
London Exchange · UK · prices in GBP · close of 22 Oct 2026
Key indicators
| Last close | GBP 339.25 |
|---|---|
| 52-week range | 322.50 – 406.00 |
| Return, 1 month / 3 months | −0.9% / −3.4% |
| Return, 1 year / 3 years | −0.9% / +40.0% |
| Trend | Below its 200-day average |
| RSI (14) | 62 |
| Volatility (1 year) | 13.9% |
| Worst drawdown (1 year) | -19.3% |
| Average daily value traded | 0.69M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mobimo Holding AG is a Swiss real estate company based in Lucerne. It develops residential and commercial properties and manages an investment portfolio of rental buildings, including offices, retail space, industrial premises and apartments. Its customers are tenants and buyers of residential and commercial space, and its activities centre on the Swiss property market, where it both builds new projects and holds completed buildings for long-term rental income.
The shares are listed on the London Exchange in UK under the code 0QQY, and the price on this page is in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mobimo Holding AG (0QQY) trades on the London Exchange in UK. It last closed at GBP 339.25 on 22 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,863 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.9% and over the last three months it fell 3.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.6% | ||
| From 52-week high | -15.4% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.4% | ||
| 6-month return | -11.5% | ||
| 12-month return, skipping the last month | 0.1% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 13.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.3% | ||
| Liquidity | 49 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.69M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.9% |
|---|---|
| 1 month | −0.9% |
| 3 months | −3.4% |
| 6 months | −11.5% |
| 1 year | −0.9% |
| 3 years | +40.0% |
| 5 years | +9.5% |
Signals
| 50-day / 200-day average | 337.83 / 359.31 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Apr 2026 | GBX 0.0515 |
| 2 Apr 2025 | GBX 0.0510 |
| 28 Mar 2024 | GBX 0.0500 |
| 13 Apr 2023 | GBX 0.0500 |
| 14 Apr 2022 | GBX 0.1000 |
| 14 Jul 2021 | GBX 0.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.